QUALITY BY DESIGN APPROACH (QBD) FOR THE SIMULTANEOUS ESTIMATION OF CANDESARTAN CILEXETIL AND AMLODIPINE BESYLATE BY RP–HPLC

INDIAN DRUGS ◽  
2020 ◽  
Vol 57 (08) ◽  
pp. 41-52
Author(s):  
Ankita Kamli ◽  
Megha Shah ◽  
Madhuri Hinge

A revers phase liquid chromatographic technique has been developed for the separation and determination of candesartan cilexetil and amlodipine besylate using QbD (Quality by Design) approach. The present method was optimised by introducing experimental design approach to identify the chromatographic conditions for adequate separation quality and minimal analysis duration. The relation between independent variables and critical quality attributes is given by experimental design methodology. The separation was achieved on shim-pack solar C18 type column (250 mm × 4.6 mm, 5 µm) as stationary phase; acetonitrile: phosphate buffer pH 6.8 (82:18, v/v); 1.0 ml/min as flow rate; detection wavelength 235 nm. The chromatographic efficiency was investigated for the factorial effect of percentage organic phase and flow rate and finely optimized by employing factorial design experiment. The method was validated and was found to be accurate, precise and robust.

Author(s):  
Pintu B Prajapati ◽  
Kajal V Jayswal ◽  
Shailesh A Shah

ABSTRACT Background Numerous RP-HPLC and HPTLC methods have been reported for estimation of fixed-dose combination (FDC) products of aspirin with anti-hypertensive and anti-lipidemic drugs. Each FDC of aspirin needed separate and dedicated chromatographic condition for its analysis. No Chromatography method has been reported yet for simultaneous estimation of FDC products of aspirin using the single chromatography condition. Objectives Hence, the multipurpose-HPTLC method was developed for simultaneous estimation of some FDC products of aspirin using enhanced analytical quality by design approach based on DoE and risk-based DMAIC principle to save solvent, cost and time of analysis. Methods The risk-based DMAIC process was carried out with identification of potential method risk parameters and their assessment using RPN ranking and filtering. The DoE-based DMAIC process was carried out by the implementation of fractional factorial and full factorial design. Results The mobile phase composition and volume of modifier were found to be critical method risk parameters for resolution of all peaks. The developed method was found to be validated, and assay results of all FDC products of aspirin were found to be in good agreement with their respective labelled claim. Conclusion The developed method is found to be solvent, cost and time saving and also fulfilled the analytical requirements of many reported chromatography methods. Hence, the developed method is the multipurpose-chromatography for analysis of FDC products of aspirin. Highlights DoE and Risk-based DMAIC principle to development of the multipurpose-chromatography method. Application of the developed method for the estimation of eight different FDC products of aspirin


Sign in / Sign up

Export Citation Format

Share Document